CN101695566A - Chinese medicament for treating cephalagra - Google Patents
Chinese medicament for treating cephalagra Download PDFInfo
- Publication number
- CN101695566A CN101695566A CN200910229482A CN200910229482A CN101695566A CN 101695566 A CN101695566 A CN 101695566A CN 200910229482 A CN200910229482 A CN 200910229482A CN 200910229482 A CN200910229482 A CN 200910229482A CN 101695566 A CN101695566 A CN 101695566A
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- radix
- rhizoma
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating cephalagra, which is prepared from the following raw materials in part by weight: 5 to 10 parts of siberian cocklour fruit, 8 to 10 parts of fiveleaf gynostemma herb, 10 to 12 parts of diverse wormwood herb, 4 to 6 parts of puff-ball, 4 to 6 parts of blackberrykiky rhizome, 4 to 6 parts of ephedra herb, 8 to 10 parts of eucalyptus leaf, 6 to 8 parts of perilla, 4 to 6 parts of small centipeda herb, 8 to 12 parts of chrysanthemum, 8 to 10 parts of mint, 15 to 20 parts of szechuan lovage rhizome, 15 to 20 parts of nutgrass galingale rhizome, 3 to 5 parts of Chinese angelica, 3 to 5 parts of dahurian angelica root, 3 to 5 parts of incised notopterygium rhizome, 3 to 5 parts of doubleteeth pubescent, 3 to 5 parts of swordlike atractylodes rhizome, 3 to 5 parts of divaricate saposhnikovia root, 3 to 5 parts of dwarf lilyturf tuber, 4 to 6 parts of baical skullcap root, 2 to 4 parts of simpleleaf shrub chastetree fruit, 2 to 4 parts of chrysanthemum, 1 to 3 parts of manchurian wildginger, 1 to 3 parts of liquoric root and 6 to 8 parts of fresh ginger. The Chinese medicament has the advantages of no toxic or side effects, convenient administration, easy absorption, quick response, good curative effect and low price; and follow-up visit shows that cured patients have no recrudescency up to now.
Description
(1) technical field
The invention belongs to Chinese medicine composition, relate to the migrainous Chinese medicine of a kind of treatment.
(2) background technology
Migraine is a kind of headache of periodical attack, and the international association of having a headache is defined as intermittent headache outbreak with migraine and with autonomic imbalance, has or absence of aura.Migraine has two major types: migraine also has other rare type with tendency (being once called as classical migraine) and Migraine without aura (being once called as common migraine).Morbidity can be estimated to account for 15%～20% in general crowd.Prevalence women is 20%～25%, and the male is 15%～20%.The patient is in the majority with the women, accounts for 72%.Falling ill first, it is extremely rare to account for 25%, 45 years old sequela of patient person below 10 years old.There is family history person to account for 45%～55%.
The migrainous Western medicine of treatment mainly is the triptan medicine at present, but costs an arm and a leg, and side effect is arranged.The traditional Chinese medical science to migrainous understanding for a long time, the treatment comprise Coryza Treated by Syndrome Differentiation, special side's treatment, acupuncture and other therapy, the traditional Chinese medical herbal treatment migraine has sure curative effect, and few side effects; Pure Chinese medicinal preparation is treated migrainous occupation mode at present, maximum decocting cooking method or decoction and alcohol sedimentation technique, the medicinal liquid that obtains directly uses or is processed into required dosage form, volatile position or water soluble part then are difficult to keep in the active component of crude drug, also are to say that the active component in the raw material is difficult to farthest extract and keep.
Solution of the present invention is based on motherland's medical science to migrainous understanding and Therapeutic Principle, achieve with reference to modern pharmacological research, from motherland's medicine treasure-house, filter out the Chinese medicine Rhizoma Chuanxiong of blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping, and the Chinese medicine Rhizoma Cyperi of the resolving depression of regulating the flow of vital energy, menstruction regulating and pain relieving, under traditional Chinese medicine theory instructs, adopt modern biological medicine technology, extract the effective active composition of Chinese crude drug (Rhizoma Cyperi and Rhizoma Chuanxiong) to greatest extent, and the screening of the best proportioning of process, make pure Chinese medicinal preparation, the treatment migraine has good effect.
(3) summary of the invention
The present invention is in order to remedy the deficiencies in the prior art, the migrainous Chinese medicine of treatment that provide a kind of instant effect, good effect, have no side effect, price is low.
The present invention is achieved through the following technical solutions:
The migrainous Chinese medicine of treatment of the present invention, its special character is: the raw material by following parts by weight is made: Fructus Xanthii 5-10 part, Herb Gynostemmae Pentaphylli 8-10 part, Herba Artemisiae Anomalae 10-12 part, Lasiosphaera Seu Calvatia 4-6 part, Rhizoma Belamcandae 4-6 part, Herba Ephedrae 4-6 part, Folium eucalypti globueli (Eucalyptus globulus Labill.) 8-10 part, Folium Perillae 6-8 part, Herba Centipedae 4-6 part, Flos Chrysanthemi 8-12 part, Herba Menthae 8-10 part, Rhizoma Chuanxiong 15-20 part, Rhizoma Cyperi 15-20 part, Radix Angelicae Sinensis 3-5 part, Radix Angelicae Dahuricae 3-5 part, Rhizoma Et Radix Notopterygii 3-5 part, Radix Angelicae Pubescentis 3-5 part, Rhizoma Atractylodis 3-5 part, Radix Saposhnikoviae 3-5 part, Radix Ophiopogonis 3-5 part, Radix Scutellariae 4-6 part, Fructus Viticis 2-4 part, Flos Chrysanthemi 2-4 part, Herba Asari 1-3 part, Radix Glycyrrhizae 1-3 part, the bright product 6-8 of Rhizoma Zingiberis Recens part.
Preparation method: all raw materials are mixed, and it is carried out sterilization processing with Burdick lamp; Then, put people's baking box to pharmaceutical drying, with pulverizer medicine is pulverized, be ground into the powder face then, restir is evenly packed in the hard capsule, packs.
Usage and dosage: oral, every day three times, each three hard capsules.
Data is summed up in clinical research
1 clinical observation:
(1) physical data:
223 routine patients are carried out clinical observation treatment.Male's 100 examples wherein, women's 123 examples, the age 14 was the migraine that a variety of causes causes to 75 years old.
(2) Therapeutic Method:
Oral, every day three times, each three hard capsules.The men and women adult can take.
(3) efficacy assessment standard:
Cure: migrainous clinical symptoms sign disappears, and it is normal that functional activity recovers.
Produce effects: the basic or big portion of migrainous clinical symptoms sign disappears.
Effectively: the migraine clinical symptoms is clearly better or takes a turn for the better.
Invalid: the clinical symptoms sign does not have improvement.
(4) therapeutic effect:
Clinical cure 203 examples account for 91%; Produce effects 16 examples account for 7%; Effective 4 examples account for 2%; Invalid 0 example; Total effective rate 100%.
The invention has the beneficial effects as follows, have no side effect, taking convenience, be easy to absorption, instant effect, good effect, price is low, effect is rapid, meet relevant national standard through check, confirm instant effect through observation on Clinical Application, have long-acting, quick-acting and characteristics of high efficiency, healing person follows up a case by regular visits to and does not see recurrence so far.
(4) specific embodiment
Embodiment 1
The migrainous Chinese medicine of treatment of the present invention is made by the raw material of following weight: Fructus Xanthii 8 grams, Herb Gynostemmae Pentaphylli 9 grams, Herba Artemisiae Anomalae 11 grams, Lasiosphaera Seu Calvatia 5 grams, Rhizoma Belamcandae 5 grams, Herba Ephedrae 5 grams, Folium eucalypti globueli (Eucalyptus globulus Labill.) 9 grams, Folium Perillae 7 grams, Herba Centipedae 5 grams, Flos Chrysanthemi 10 grams, Herba Menthae 9 grams, Rhizoma Chuanxiong 17 grams, Rhizoma Cyperi 18 grams, Radix Angelicae Sinensis 4 grams, the Radix Angelicae Dahuricae 4 grams, Rhizoma Et Radix Notopterygii 4 grams, Radix Angelicae Pubescentis 4 grams, Rhizoma Atractylodis 4 grams, Radix Saposhnikoviae 4 grams, restrain Radix Ophiopogonis 4, Radix Scutellariae 5 grams, Fructus Viticis 3 grams, Flos Chrysanthemi 3 grams, Herba Asari 2 grams, Radix Glycyrrhizae 2 grams, bright product 7 grams of Rhizoma Zingiberis Recens.
Preparation method: all raw materials are mixed, and it is carried out sterilization processing with Burdick lamp; Then, put people's baking box to pharmaceutical drying, with pulverizer medicine is pulverized, be ground into the powder face then, restir is evenly packed in the hard capsule, packs.
Usage and dosage: oral, every day three times, each three hard capsules.
Embodiment 2
The migrainous Chinese medicine of treatment of the present invention is made by the raw material of following weight: Fructus Xanthii 5 grams, Herb Gynostemmae Pentaphylli 8 grams, Herba Artemisiae Anomalae 10 grams, Lasiosphaera Seu Calvatia 4 grams, Rhizoma Belamcandae 4 grams, Herba Ephedrae 4 grams, Folium eucalypti globueli (Eucalyptus globulus Labill.) 8 grams, Folium Perillae 6 grams, Herba Centipedae 4 grams, Flos Chrysanthemi 8 grams, Herba Menthae 8 grams, Rhizoma Chuanxiong 15 grams, Rhizoma Cyperi 15 grams, Radix Angelicae Sinensis 3 grams, the Radix Angelicae Dahuricae 3 grams, Rhizoma Et Radix Notopterygii 3 grams, Radix Angelicae Pubescentis 3 grams, Rhizoma Atractylodis 3 grams, Radix Saposhnikoviae 3 grams, restrain Radix Ophiopogonis 3, Radix Scutellariae 4 grams, Fructus Viticis 2 grams, Flos Chrysanthemi 2 grams, Herba Asari 1 gram, Radix Glycyrrhizae 1 gram, bright product 6 grams of Rhizoma Zingiberis Recens.
All the other are identical with embodiment 1.
Embodiment 3
The migrainous Chinese medicine of treatment of the present invention is made by the raw material of following weight: Fructus Xanthii 10 grams, Herb Gynostemmae Pentaphylli 10 grams, Herba Artemisiae Anomalae 12 grams, Lasiosphaera Seu Calvatia 6 grams, Rhizoma Belamcandae 6 grams, Herba Ephedrae 6 grams, Folium eucalypti globueli (Eucalyptus globulus Labill.) 10 grams, Folium Perillae 8 grams, Herba Centipedae 6 grams, Flos Chrysanthemi 12 grams, Herba Menthae 10 grams, Rhizoma Chuanxiong 20 grams, Rhizoma Cyperi 20 grams, Radix Angelicae Sinensis 5 grams, the Radix Angelicae Dahuricae 5 grams, Rhizoma Et Radix Notopterygii 5 grams, Radix Angelicae Pubescentis 5 grams, Rhizoma Atractylodis 5 grams, Radix Saposhnikoviae 5 grams, restrain Radix Ophiopogonis 5, Radix Scutellariae 6 grams, Fructus Viticis 4 grams, Flos Chrysanthemi 4 grams, Herba Asari 3 grams, Radix Glycyrrhizae 3 grams, bright product 8 grams of Rhizoma Zingiberis Recens.
All the other are identical with embodiment 1.
Claims (1)
1. treat migrainous Chinese medicine for one kind, it is characterized in that: the raw material by following parts by weight is made: Fructus Xanthii 5-10 part, Herb Gynostemmae Pentaphylli 8-10 part, Herba Artemisiae Anomalae 10-12 part, Lasiosphaera Seu Calvatia 4-6 part, Rhizoma Belamcandae 4-6 part, Herba Ephedrae 4-6 part, Folium eucalypti globueli (Eucalyptus globulus Labill.) 8-10 part, Folium Perillae 6-8 part, Herba Centipedae 4-6 part, Flos Chrysanthemi 8-12 part, Herba Menthae 8-10 part, Rhizoma Chuanxiong 15-20 part, Rhizoma Cyperi 15-20 part, Radix Angelicae Sinensis 3-5 part, Radix Angelicae Dahuricae 3-5 part, Rhizoma Et Radix Notopterygii 3-5 part, Radix Angelicae Pubescentis 3-5 part, Rhizoma Atractylodis 3-5 part, Radix Saposhnikoviae 3-5 part, Radix Ophiopogonis 3-5 part, Radix Scutellariae 4-6 part, Fructus Viticis 2-4 part, Flos Chrysanthemi 2-4 part, Herba Asari 1-3 part, Radix Glycyrrhizae 1-3 part, the bright product 6-8 of Rhizoma Zingiberis Recens part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910229482A CN101695566A (en) | 2009-10-27 | 2009-10-27 | Chinese medicament for treating cephalagra |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910229482A CN101695566A (en) | 2009-10-27 | 2009-10-27 | Chinese medicament for treating cephalagra |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101695566A true CN101695566A (en) | 2010-04-21 |
Family
ID=42140719
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910229482A Pending CN101695566A (en) | 2009-10-27 | 2009-10-27 | Chinese medicament for treating cephalagra |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101695566A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102217883A (en) * | 2011-03-17 | 2011-10-19 | 上海韬鸿化工科技有限公司 | Chinese medicinal pillow capable of treating cervical spondylopathy |
| CN102217884A (en) * | 2011-03-17 | 2011-10-19 | 上海韬鸿化工科技有限公司 | Chinese medicinal pillow |
| CN102217879A (en) * | 2011-03-17 | 2011-10-19 | 上海韬鸿化工科技有限公司 | Heart-nourishing and nerve-soothing pillow |
| CN103007027A (en) * | 2012-12-06 | 2013-04-03 | 南通市华东润滑设备有限公司 | Pill for treating migraine |
| CN103623093A (en) * | 2013-11-18 | 2014-03-12 | 聂克德 | Traditional Chinese medicine formula for treating migraine |
| CN103816367A (en) * | 2014-03-05 | 2014-05-28 | 济南伟传信息技术有限公司 | Traditional Chinese medicine for treating migraine |
| CN104984089A (en) * | 2015-06-30 | 2015-10-21 | 覃洪质 | Migraine treating capsule |
-
2009
- 2009-10-27 CN CN200910229482A patent/CN101695566A/en active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102217883A (en) * | 2011-03-17 | 2011-10-19 | 上海韬鸿化工科技有限公司 | Chinese medicinal pillow capable of treating cervical spondylopathy |
| CN102217884A (en) * | 2011-03-17 | 2011-10-19 | 上海韬鸿化工科技有限公司 | Chinese medicinal pillow |
| CN102217879A (en) * | 2011-03-17 | 2011-10-19 | 上海韬鸿化工科技有限公司 | Heart-nourishing and nerve-soothing pillow |
| CN102217879B (en) * | 2011-03-17 | 2014-10-01 | 上海韬鸿化工科技有限公司 | Heart-nourishing and nerve-soothing pillow |
| CN102217884B (en) * | 2011-03-17 | 2014-11-05 | 上海韬鸿化工科技有限公司 | Chinese medicinal pillow |
| CN103007027A (en) * | 2012-12-06 | 2013-04-03 | 南通市华东润滑设备有限公司 | Pill for treating migraine |
| CN103623093A (en) * | 2013-11-18 | 2014-03-12 | 聂克德 | Traditional Chinese medicine formula for treating migraine |
| CN103816367A (en) * | 2014-03-05 | 2014-05-28 | 济南伟传信息技术有限公司 | Traditional Chinese medicine for treating migraine |
| CN104984089A (en) * | 2015-06-30 | 2015-10-21 | 覃洪质 | Migraine treating capsule |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101695566A (en) | Chinese medicament for treating cephalagra | |
| CN102302751B (en) | Chinese medicine for treating migraine | |
| CN102416145B (en) | Chinese medicinal composition for treating menstrual disorder | |
| CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
| CN1903299A (en) | Traditional Chinese medicine decoction for treating-ache and expelling atagnate | |
| CN104758529A (en) | Traditional Chinese medicine composition for treating common cold due to wind-cold | |
| CN102274395A (en) | Traditional Chinese medicine for treating rhinitis | |
| CN103800601A (en) | Traditional Chinese medicine composition for treating hepatitis | |
| CN101623455B (en) | Medicine for treating prostate hyperplasia | |
| CN103845617A (en) | Medicament for treating latent glomerulonephritis | |
| CN103479835A (en) | Traditional Chinese medicine for treating liver cirrhosis | |
| CN103316228A (en) | Scorpio unsting wine | |
| CN103550533B (en) | Chinese medicine composition for treating headache during menstruation | |
| CN102784311B (en) | Traditional Chinese medicine composition for curing women's puerperal diseases and preparation method of traditional Chinese medicine composition | |
| CN105079515A (en) | Traditional Chinese medicine composition for treating post-traumatic headache | |
| CN1175875C (en) | Medicine made of lysimachia for treating hepatobiliary calculus and its prescription | |
| CN108014222A (en) | Treat medicinal liquor of rheumatism and preparation method thereof | |
| CN102416150B (en) | Chinese medicinal composition for treating diarrhoea | |
| CN101444616B (en) | Medicated wine for curing chronic rheumatism and method for preparing same | |
| CN103800809A (en) | Traditional Chinese medicinal preparation for treating liver diseases | |
| CN102038834A (en) | Traditional Chinese medicine preparation for preventing and treating cancers | |
| CN105770548A (en) | Externally-used traditional Chinese medicine for treating skin eczema | |
| CN105250956A (en) | Chinese herb composition for treating colitis | |
| CN104800599A (en) | Traditional Chinese medicinal composition for treating deficiency of kidney-yin | |
| CN104758539A (en) | Traditional Chinese medicine composition for treating debilitation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20100421 |